Literature DB >> 11121197

Failure to replicate an association between the catechol-O-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort.

I Manor1, M Kotler, Y Sever, J Eisenberg, H Cohen, R P Ebstein, S Tyano.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a developmental syndrome expressed along three domains: inattention, hyperactive-impulsive, and combined type. Both environmental and genetic factors contribute to the etiology of this complex disease. We previously reported an association in 48 ADHD triads (both parents and proband) between the catechol-O-methyl- transferase (COMT) polymorphism (especially the high enzyme activity val allele) and the Diagnostic and Statistical Manual of Mental Disorders (DSM IV) combined category (excluding inattention) of ADHD (however, see erratum, Am. J. Med. Genet. [Neuropsychiatr. Genet.] 96:893). In the current report, we attempted to replicate this finding in an independently recruited group of 70 nuclear families using the haplotype relative risk design. In the current investigation, no evidence for association of the COMT polymorphism and ADHD (or any of the DSM IV subtypes) was observed in either the current cohort or the expanded cohort of 118 Israeli triads. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:858-860, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121197     DOI: 10.1002/1096-8628(20001204)96:6<858::aid-ajmg33>3.0.co;2-8

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

Review 1.  Genes and attention deficit hyperactivity disorder.

Authors:  J Swanson; M Posner; J Fusella; M Wasdell; T Sommer; J Fan
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

Review 2.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

3.  The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD.

Authors:  Mark A Bellgrove; Katharina Domschke; Ziarih Hawi; Aiveen Kirley; Celine Mullins; Ian H Robertson; Michael Gill
Journal:  Exp Brain Res       Date:  2005-01-15       Impact factor: 1.972

Review 4.  Dopamine genes and attention-deficit hyperactivity disorder: a review.

Authors:  Salvatore DiMaio; Nathalie Grizenko; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

5.  Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant.

Authors:  Haukur Pálmason; Dirk Moser; Jessica Sigmund; Christian Vogler; Susann Hänig; Anna Schneider; Christiane Seitz; Alexander Marcus; Jobst Meyer; Christine M Freitag
Journal:  J Neural Transm (Vienna)       Date:  2009-11-28       Impact factor: 3.575

6.  COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD.

Authors:  Sarojini Sengupta; Natalie Grizenko; Norbert Schmitz; George Schwartz; Johanne Bellingham; Anna Polotskaia; Marina Ter Stepanian; Yukiori Goto; Anthony A Grace; Ridha Joober
Journal:  Neuropsychopharmacology       Date:  2008-06-25       Impact factor: 7.853

Review 7.  Candidate gene studies of ADHD: a meta-analytic review.

Authors:  Ian R Gizer; Courtney Ficks; Irwin D Waldman
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

8.  Association of Val158Met polymorphism in COMT gene with attention-deficit hyperactive disorder: An updated meta-analysis.

Authors:  Peipei Kang; Limei Luo; Xiling Peng; Yanhu Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

9.  No evidence of association between Catechol-O-Methyltransferase (COMT) Val158Met genotype and performance on neuropsychological tasks in children with ADHD: a case-control study.

Authors:  Sophie Mills; Kate Langley; Marianne Van den Bree; Eddy Street; Darko Turic; Michael J Owen; Michael C O'Donovan; Anita Thapar
Journal:  BMC Psychiatry       Date:  2004-06-07       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.